Why Do We Need a New BRAF-MEK Inhibitor Combination in Melanoma?
Oncology in Clinical Practice - Poland
doi 10.5603/ocp.2018.0054
Full Text
Open PDFAbstract
Available in full text
Categories
Date
May 17, 2019
Authors
Publisher
VM Media SP. zo.o VM Group SK